Ninety One (UK)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-87,703
| Closed | -$2.43M | – | 200 |
|
|
2024
Q1 | $2.43M | Buy |
+87,703
| New | +$2.43M | 0.01% | 173 |
|
|
2022
Q1 | – | Sell |
-292,924
| Closed | -$17.3M | – | 212 |
|
|
2021
Q4 | $17.3M | Buy |
+292,924
| New | +$14.5M | 0.04% | 154 |
|
|
2019
Q4 | – | Sell |
-132,028
| Closed | -$4.5M | – | 256 |
|
|
2019
Q3 | $4.5M | Sell |
132,028
-192,162
| -59% | -$6.99M | 0.02% | 201 |
|
|
2019
Q2 | $13.3M | Sell |
324,190
-52,540
| -14% | -$2.09M | 0.05% | 182 |
|
|
2019
Q1 | $15.2M | Sell |
376,730
-4,824,278
| -93% | -$193M | 0.06% | 173 |
|
|
2018
Q4 | $215M | Buy |
5,201,008
+116,985
| +2% | +$4.86M | 0.93% | 31 |
|
|
2018
Q3 | $213M | Buy |
5,084,023
+429,000
| +9% | +$16.5M | 0.79% | 39 |
|
|
2018
Q2 | $160M | Buy |
4,655,023
+133,416
| +3% | +$4.56M | 0.8% | 41 |
|
|
2018
Q1 | $152M | Sell |
4,521,607
-848,067
| -16% | -$29.2M | 0.82% | 36 |
|
|
2017
Q4 | $185M | Sell |
5,369,674
-73,175
| -1% | -$2.5M | 0.76% | 46 |
|
|
2017
Q3 | $184M | Buy |
5,442,849
+2,176
| +0% | +$69.9K | 0.81% | 40 |
|
|
2017
Q2 | $173M | Sell |
5,440,673
-2,342,698
| -30% | -$73.9M | 0.83% | 43 |
|
|
2017
Q1 | $253M | Sell |
7,783,371
-159,185
| -2% | -$5.02M | 1.25% | 18 |
|
|
2016
Q4 | $245M | Buy |
7,942,556
+9,714
| +0.1% | +$297K | 1.28% | 20 |
|
|
2016
Q3 | $255M | Buy |
7,932,842
+73,233
| +0.9% | +$2.45M | 1.24% | 22 |
|
|
2016
Q2 | $263M | Sell |
7,859,609
-33,770
| -0.4% | -$1.08M | 1.36% | 14 |
|
|
2016
Q1 | $222M | Sell |
7,893,379
-256,867
| -3% | -$7.34M | 1.2% | 23 |
|
|
2015
Q4 | $250M | Sell |
8,150,246
-34,766
| -0.4% | -$1.09M | 1.42% | 17 |
|
|
2015
Q3 | $244M | Sell |
8,185,012
-5,873
| -0.1% | -$188K | 1.53% | 12 |
|
|
2015
Q2 | $261M | Sell |
8,190,885
-509,070
| -6% | -$16.6M | 1.49% | 14 |
|
|
2015
Q1 | $287M | Buy |
8,699,955
+409,601
| +5% | +$13M | 1.68% | 7 |
|
|
2014
Q4 | $245M | Sell |
8,290,354
-4,329,336
| -34% | -$124M | 1.5% | 12 |
|
|
2014
Q3 | $354M | Buy |
12,619,690
+412,776
| +3% | +$11.6M | 2.09% | 3 |
|
|
2014
Q2 | $344M | Sell |
12,206,914
-2,605,516
| -18% | -$74.3M | 1.99% | 2 |
|
|
2014
Q1 | $451M | Sell |
14,812,430
-177,653
| -1% | -$5.3M | 3.01% | 2 |
|
|
2013
Q4 | $436M | Buy |
14,990,083
+99,847
| +0.7% | +$2.91M | 3.04% | 1 |
|
|
2013
Q3 | $406M | Sell |
14,890,236
-13,771
| -0.1% | -$375K | 2.98% | 1 |
|
|
2013
Q2 | $396M | Buy |
+14,904,007
| New | +$412M | 3.04% | 1 |
|
Other funds holding PFE
Ninety One (UK)'s PFE Position: Q2 2024 in Review
Ninety One (UK) sold out of Pfizer (PFE) in Q2 2024, closing a stake of 87,703 shares — an estimated $2.43M sold.
Ninety One (UK) first reported a position in PFE in Q2 2013 and held it in 28 quarters. The position peaked at $451M in Q1 2014. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.
- Ninety One (UK) reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
- Ninety One (UK) sold 87,703 Pfizer shares in Q2 2024, an estimated $2.43M.
- Ninety One (UK) first reported a position in Pfizer in Q2 2013 and held it in 28 quarters.
- Ninety One (UK)'s Pfizer position peaked at $451M in Q1 2014.
- 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.
Based on Ninety One (UK)'s 13F filing for Q2 2024, filed 22 Jul 2024.